(Q39208882)

10 September 2017

mTOR pathway as a potential target in a subset of human medulloblastoma (English)

1 reference

10 September 2017

0 references

7

Zsuzsanna Jakab

1 reference

10 September 2017

Tímea Pócza

1

1 reference

10 September 2017

Anna Sebestyén

2

1 reference

10 September 2017

Eszter Turányi

3

1 reference

10 September 2017

Tibor Krenács

4

1 reference

10 September 2017

Agnes Márk

5

1 reference

10 September 2017

Tamás Béla Sticz

6

1 reference

10 September 2017

Péter Hauser

8

1 reference

10 September 2017

16 April 2014

1 reference

Pathology Oncology Research

10 September 2017

1 reference

10 September 2017

20

1 reference

10 September 2017

4

1 reference

10 September 2017

893-900

1 reference

https://scigraph.springernature.com/pub.10.1007/s12253-014-9771-0

10 September 2017

0 references

cites work

Development and cancer of the cerebellum

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Cerebellum development and medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Medulloblastoma in childhood: new biological advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Chemotherapy for malignant brain tumors of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

mTOR signaling in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

PI3K and mTOR signaling pathways in cancer: new data on targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Rapamycin regulates the phosphorylation of rictor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Phase I study of everolimus in pediatric patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Double trouble: when sonic hedgehog signaling meets TSC inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Divergent functions for eIF4E and S6 kinase by sonic hedgehog mitogenic signaling in the developing cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

An animal model of MYC-driven medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

The expanding relevance of nuclear mTOR in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Pathogenesis of medulloblastoma and current treatment outlook.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

mTOR links oncogenic signaling to tumor cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Co-expression of EGF receptor, TGFalpha and S6 kinase is significantly associated with colorectal carcinomas with distant metastases at diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Determinants of rapamycin sensitivity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Preliminary experience with personalized and targeted therapy for pediatric brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9771-0

Activation of Akt and Erk pathways in medulloblastoma.

21 January 2018

1 reference

12 December 2020

Favourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation.

1 reference

12 December 2020

Childhood medulloblastoma

1 reference

12 December 2020

Ribosomal protein S6 phosphorylation is associated with epithelial dysplasia and squamous cell carcinoma of the oral cavity

1 reference

12 December 2020

Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.

1 reference

12 December 2020

Insulin-like growth factor I receptor activity in human medulloblastomas.

1 reference

12 December 2020

Implication of active Erk in the classic type of human medulloblastoma

1 reference

12 December 2020

10.1007/S12253-014-9771-0

Identifiers

DOI

1 reference

release_qn2q5sag2nez5ey3xjs347sbnu

10 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qn2q5sag2nez5ey3xjs347sbnu

24 November 2022

mapped directly with Wikidata item

1 reference